What is eb
Last updated: April 1, 2026
Key Facts
- Epidermolysis Bullosa affects approximately 1 in 50,000 births globally, though estimates vary by region and diagnosis criteria
- There are three major types of EB: simplex (mildest form affecting top skin layer), junctional (moderate severity), and dystrophic (most severe form)
- EB is caused by mutations in genes responsible for producing proteins that anchor skin layers together, primarily collagen and adhesion molecules
- People with EB require specialized wound care, pain management, and monitoring for complications including infections and increased skin cancer risk
- While there is no cure for EB, various treatments and management strategies can improve quality of life, with gene therapy showing promise in research
Overview
Epidermolysis Bullosa, commonly known as EB, is a group of rare inherited genetic disorders characterized by extreme fragility of the skin and mucous membranes. The condition causes blistering and painful sores that result from minor trauma, friction, or pressure that would not normally damage skin. EB affects the connective tissues that hold the various layers of skin together, making it vulnerable to breakdown. The severity and manifestation of the disease vary widely depending on the type of EB, ranging from localized blistering to severe systemic involvement affecting multiple organs. Though rare, EB represents a significant health challenge for those affected and their families.
Types of Epidermolysis Bullosa
There are three major types of EB, classified by the level of the skin where blistering occurs. Epidermolysis Bullosa Simplex (EBS) is the mildest form, affecting the top layer of skin and typically causing localized blistering on the hands and feet. Junctional Epidermolysis Bullosa (JEB) affects the area where the top layer of skin meets the layers below and is moderate to severe. Dystrophic Epidermolysis Bullosa (DEB) is the most severe form, affecting the deepest layers of skin and often resulting in scarring and loss of function. Within these three categories, there are multiple subtypes based on genetic mutations and specific characteristics.
Causes and Genetics
EB is caused by mutations in genes responsible for producing proteins that serve as "anchors" holding skin layers together, primarily collagen and adhesion proteins. These proteins are essential for maintaining the structural integrity and elasticity of the skin. Mutations in genes such as KRT5, KRT14, COL7A1, and others prevent the body from producing these proteins correctly or in sufficient quantities. EB is inherited in either an autosomal dominant or autosomal recessive pattern, depending on the type. Genetic testing can identify the specific mutations responsible for an individual's EB, which helps with diagnosis, prognosis, and family planning.
Symptoms and Daily Challenges
The primary symptom of EB is severe blistering and skin breakdown from minor trauma or friction. People with EB must take precautions to avoid injury, as activities that most people consider normal—such as walking, writing, or self-care—can cause severe blistering. Patients often experience chronic pain from wounds and infections. Depending on the type and severity, EB can affect mucous membranes in the mouth, throat, and gastrointestinal tract, causing difficulty eating, swallowing, and digestion. Managing daily activities requires careful attention to preventing injuries and maintaining wound care routines that can be time-consuming and emotionally challenging.
Treatment and Management
While there is no cure for EB, various treatments and management strategies help reduce symptoms and complications. Wound care is essential and typically includes gentle cleaning, specialized dressings that minimize friction, and infection prevention. Pain management is often necessary, as wounds can be quite painful. Medical teams may recommend protective clothing and modifications to the home environment to reduce the risk of injury. Physical and occupational therapy can help maximize function and independence. Research is ongoing to develop new treatments, including gene therapy approaches that show promise for some types of EB. Psychological support for patients and families is also important, as the condition can significantly impact quality of life and mental health.
Related Questions
Is Epidermolysis Bullosa (EB) contagious?
No, EB is not contagious. It is a genetic disorder inherited from parents, not an infection that can be spread to others. Children of parents with EB have a risk of inheriting the condition based on the genetic inheritance pattern.
Can EB be cured?
Currently, there is no cure for Epidermolysis Bullosa, though various treatments can manage symptoms and improve quality of life. Research into gene therapy and other advanced treatments is ongoing with promising early results.
What is the life expectancy for someone with EB?
Life expectancy varies greatly depending on the type and severity of EB. Some forms have minimal impact on lifespan, while severe forms may shorten life expectancy. Proper care, infection prevention, and medical management can significantly improve outcomes.
More What Is in Daily Life
Also in Daily Life
More "What Is" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
- Wikipedia - Epidermolysis BullosaCC-BY-SA-4.0
- DEBRA International - EB Advocacy OrganizationProprietary
- NINDS - Epidermolysis BullosaPublic Domain